Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04652076 |
Title | GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or Pembrolizumab (GYNET) |
Acronym | GYNET |
Recruitment | Active, not recruiting |
Gender | female |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | NETRIS Pharma |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | FRA |